Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages

Atherosclerosis

Volumn 160, Issue 1, 2002, Pages 11-20

  Fu, Yuchang ^a   Luo, Nanlan ^a   Lopes Virella, Maria F ^a,b  

^a Division of Endocrinology   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

15 Deoxy delta12, 14 prostaglandin J2; Atherosclerosis; Interleukin 8; THP 1 macrophage

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHOLESTEROL; DELTA12 PROSTAGLANDIN J2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN D2; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR;

ARTICLE; ATHEROSCLEROSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; MACROPHAGE; METABOLITE; PEROXISOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BIOLOGICAL RESPONSE MODIFIERS; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERLEUKIN-8; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0036145237     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00541-X     Document Type: Article

References (39)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Low density lipoprotein oxidation and its pathobiological significance
3. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor
4. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8
5. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma
6. Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production
7. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages
8. Interleukin-8 as a macrophage-derived mediator of angiogenesis
9. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes
10. Interleukin-8 is chemotactic for vascular smooth muscle cells
11. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells
12. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
13. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
14. PPARs: A nuclear receptor signaling pathway in lipid metabolism
15. mPPAR gamma 2: Tissue-specific regulator of an dipocyte enhancer
16. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα
17. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
18. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor (PPARγ)
19. The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
20. 15-Deoxy-delta12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma
21. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ
22. PPARγ promoters monocyte/macrophage differentiation and uptake of oxidized LDL
23. Expression of the peroxisome proliferator-activated receptor gamma (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
24. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth cells
25. PPARγ agonists inhibit production of monocyte inflammatory cytokines
26. The peroxisome proliferator-activated receptor gamma is a negative regulator of macrophage activation
27. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages
28. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells
29. Linoleic acid and its metabolites, hydroperoxyoctadecadienoic acids, stimulate c-Fos, c-Jun, and c-Myc mRNA expression, mitogen-activated protein kinases activation, and growth in rat aortic smooth muscle cells
30. Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein
31. NF-κB: A lesson in family values
32. Function and activation of NF-κB in the immune system
33. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells
34. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes
35. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms
36. 15-Deoxy-12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway
37. PPARs: A nuclear receptor signaling pathway in lipid metabolism
38. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NF-κB
39. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I[kappa B]kinase